Cybin Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

265.69M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	-	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	686.88K	-	-
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Cellectis	79.59M
Codexis	78.09M
Compugen	72.76M
Arcturus Therapeutics Holdings	54.71M
Coherus Oncology	42.17M
Foghorn Therapeutics	28.22M
Cartesian Therapeutics	1.78M
Artiva Biotherapeutics	251.00K

Revenue Rankings

HELP News

10 days ago - CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
10 days ago - Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference - GlobeNewsWire
12 days ago - Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
17 days ago - Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan - GlobeNewsWire
20 days ago - How Trump's psychedelics executive order could unlock stalled cannabis reform - CNBC
20 days ago - Helus ‘welcomes’ Executive Order for accelerating psychedelic research - TheFly
20 days ago - Helus Pharma announces Cola is stepping down as CEO, appoints So as Interim CEO - TheFly
20 days ago - Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions - GlobeNewsWire

More News